In this review, experimental and clinical evidence on the role of the PI3K/Akt/mTOR pathway in PC as well as the possible implications of treatment with natural or synthetic mTOR inhibitors have been discussed. This evidence concerns the gene AKT1 and pachyonychia congenita.